Atypical Antipsychotic Drugs Market 2028 by Drug Class, Application, Distribution Channel and Geography | The Insight Partners

Atypical Antipsychotic Drugs Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Drug Class (First Generation, Second Generation, Third Generation (Abilify)); Application (Bipolar Disorders, Schizophrenia, Dementia, Unipolar Depression, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00005402 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

MARKET INTRODUCTION



Psychosis is a kind of metal disorder, in which a person loses connection with reality. A person may often express hallucinations, paranoia, or delusions. The conditions is being treated drugs, which are known as antipsychotic drugs which were introduced in 1990s. However, the drug development has allowed to launch new generation of the drugs which are known as atypical antipsychotics. These drugs are commonly used these days and have been further classified as first-generation, second-generation and third generation drugs.

MARKET DYNAMICS



Atypical antipsychotic drugs market is projected to grow due to growing incidences of mental disorders, increasing conditions such as hallucination and delusion among others. The market is expected to have growth opportunities such as rising drug development activities, growing pharmaceutical industry and rising investments in the healthcare industry.

MARKET SCOPE



The "Global Atypical Antipsychotic Drugs Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of atypical antipsychotic drugs market with detailed market segmentation by drug class, application, distribution channel and geography. The global atypical antipsychotic drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading atypical antipsychotic drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



The global atypical antipsychotic drugs market is segmented on the basis of drug class, application, and distribution channel. Based on the drug class the market is categorized as first generation, second generation, and third generation (Abilify). On the basis of application the market is segmented as bipolar disorders, schizophrenia, dementia, unipolar depression, and others. Based on distribution channel the market is classified as hospital pharmacies, retail pharmacies, and online pharmacies

Get more information on this report :


REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global atypical antipsychotic drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The atypical antipsychotic drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting atypical antipsychotic drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the atypical antipsychotic drugs market in these regions.

Get more information on this report :

MARKET PLAYERS



The reports cover key developments in the atypical antipsychotic drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from atypical antipsychotic drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for atypical antipsychotic drugs market in the global market. Below mentioned is the list of few companies engaged in the atypical antipsychotic drugs market.

The report also includes the profiles of key atypical antipsychotic drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Janssen Research and Development, LLC (Johnson and Johnson Services Inc)
  • Eli Lilly and Company
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • Allergan plc
  • AstraZeneca plc
  • GlaxoSmithKline Plc.
  • SANIS
  • Ranbaxy Pharmaceuticals Inc. (Sun Pharmaceutical Industries Ltd.)
  • Teva Pharmaceutical Industries Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Atypical Antipsychotic Drugs Market - By Drug Class
1.3.2 Atypical Antipsychotic Drugs Market - By Application
1.3.3 Atypical Antipsychotic Drugs Market - By Distribution Channel
1.3.4 Atypical Antipsychotic Drugs Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ATYPICAL ANTIPSYCHOTIC DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ATYPICAL ANTIPSYCHOTIC DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. ATYPICAL ANTIPSYCHOTIC DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ATYPICAL ANTIPSYCHOTIC DRUGS - GLOBAL MARKET OVERVIEW
6.2. ATYPICAL ANTIPSYCHOTIC DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. ATYPICAL ANTIPSYCHOTIC DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. FIRST GENERATION
7.3.1. Overview
7.3.2. First Generation Market Forecast and Analysis
7.3.3. Haldo Market
7.3.3.1. Overview
7.3.3.2. Haldo Market Forecast and Analysis
7.3.4. Navane Market
7.3.4.1. Overview
7.3.4.2. Navane Market Forecast and Analysis
7.3.5. Others Market
7.3.5.1. Overview
7.3.5.2. Others Market Forecast and Analysis
7.4. SECOND GENERATION
7.4.1. Overview
7.4.2. Second Generation Market Forecast and Analysis
7.4.3. Latuda Market
7.4.3.1. Overview
7.4.3.2. Latuda Market Forecast and Analysis
7.4.4. Invega Market
7.4.4.1. Overview
7.4.4.2. Invega Market Forecast and Analysis
7.4.5. Seroquel Market
7.4.5.1. Overview
7.4.5.2. Seroquel Market Forecast and Analysis
7.4.6. Risperdal Market
7.4.6.1. Overview
7.4.6.2. Risperdal Market Forecast and Analysis
7.4.7. Zyprexa Market
7.4.7.1. Overview
7.4.7.2. Zyprexa Market Forecast and Analysis
7.4.8. Geodon Market
7.4.8.1. Overview
7.4.8.2. Geodon Market Forecast and Analysis
7.4.9. Others Market
7.4.9.1. Overview
7.4.9.2. Others Market Forecast and Analysis
7.5. THIRD GENERATION (ABILIFY)
7.5.1. Overview
7.5.2. Third Generation (Abilify) Market Forecast and Analysis

8. ATYPICAL ANTIPSYCHOTIC DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. BIPOLAR DISORDERS
8.3.1. Overview
8.3.2. Bipolar Disorders Market Forecast and Analysis
8.4. SCHIZOPHRENIA
8.4.1. Overview
8.4.2. Schizophrenia Market Forecast and Analysis
8.5. DEMENTIA
8.5.1. Overview
8.5.2. Dementia Market Forecast and Analysis
8.6. UNIPOLAR DEPRESSION
8.6.1. Overview
8.6.2. Unipolar Depression Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis

9. ATYPICAL ANTIPSYCHOTIC DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis

10. ATYPICAL ANTIPSYCHOTIC DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Atypical Antipsychotic Drugs Market Overview
10.1.2 North America Atypical Antipsychotic Drugs Market Forecasts and Analysis
10.1.3 North America Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Drug Class
10.1.4 North America Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Application
10.1.5 North America Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Atypical Antipsychotic Drugs Market
10.1.6.1.1 United States Atypical Antipsychotic Drugs Market by Drug Class
10.1.6.1.2 United States Atypical Antipsychotic Drugs Market by Application
10.1.6.1.3 United States Atypical Antipsychotic Drugs Market by Distribution Channel
10.1.6.2 Canada Atypical Antipsychotic Drugs Market
10.1.6.2.1 Canada Atypical Antipsychotic Drugs Market by Drug Class
10.1.6.2.2 Canada Atypical Antipsychotic Drugs Market by Application
10.1.6.2.3 Canada Atypical Antipsychotic Drugs Market by Distribution Channel
10.1.6.3 Mexico Atypical Antipsychotic Drugs Market
10.1.6.3.1 Mexico Atypical Antipsychotic Drugs Market by Drug Class
10.1.6.3.2 Mexico Atypical Antipsychotic Drugs Market by Application
10.1.6.3.3 Mexico Atypical Antipsychotic Drugs Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Atypical Antipsychotic Drugs Market Overview
10.2.2 Europe Atypical Antipsychotic Drugs Market Forecasts and Analysis
10.2.3 Europe Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Application
10.2.5 Europe Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Atypical Antipsychotic Drugs Market
10.2.6.1.1 Germany Atypical Antipsychotic Drugs Market by Drug Class
10.2.6.1.2 Germany Atypical Antipsychotic Drugs Market by Application
10.2.6.1.3 Germany Atypical Antipsychotic Drugs Market by Distribution Channel
10.2.6.2 France Atypical Antipsychotic Drugs Market
10.2.6.2.1 France Atypical Antipsychotic Drugs Market by Drug Class
10.2.6.2.2 France Atypical Antipsychotic Drugs Market by Application
10.2.6.2.3 France Atypical Antipsychotic Drugs Market by Distribution Channel
10.2.6.3 Italy Atypical Antipsychotic Drugs Market
10.2.6.3.1 Italy Atypical Antipsychotic Drugs Market by Drug Class
10.2.6.3.2 Italy Atypical Antipsychotic Drugs Market by Application
10.2.6.3.3 Italy Atypical Antipsychotic Drugs Market by Distribution Channel
10.2.6.4 Spain Atypical Antipsychotic Drugs Market
10.2.6.4.1 Spain Atypical Antipsychotic Drugs Market by Drug Class
10.2.6.4.2 Spain Atypical Antipsychotic Drugs Market by Application
10.2.6.4.3 Spain Atypical Antipsychotic Drugs Market by Distribution Channel
10.2.6.5 United Kingdom Atypical Antipsychotic Drugs Market
10.2.6.5.1 United Kingdom Atypical Antipsychotic Drugs Market by Drug Class
10.2.6.5.2 United Kingdom Atypical Antipsychotic Drugs Market by Application
10.2.6.5.3 United Kingdom Atypical Antipsychotic Drugs Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Atypical Antipsychotic Drugs Market Overview
10.3.2 Asia-Pacific Atypical Antipsychotic Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Atypical Antipsychotic Drugs Market
10.3.6.1.1 Australia Atypical Antipsychotic Drugs Market by Drug Class
10.3.6.1.2 Australia Atypical Antipsychotic Drugs Market by Application
10.3.6.1.3 Australia Atypical Antipsychotic Drugs Market by Distribution Channel
10.3.6.2 China Atypical Antipsychotic Drugs Market
10.3.6.2.1 China Atypical Antipsychotic Drugs Market by Drug Class
10.3.6.2.2 China Atypical Antipsychotic Drugs Market by Application
10.3.6.2.3 China Atypical Antipsychotic Drugs Market by Distribution Channel
10.3.6.3 India Atypical Antipsychotic Drugs Market
10.3.6.3.1 India Atypical Antipsychotic Drugs Market by Drug Class
10.3.6.3.2 India Atypical Antipsychotic Drugs Market by Application
10.3.6.3.3 India Atypical Antipsychotic Drugs Market by Distribution Channel
10.3.6.4 Japan Atypical Antipsychotic Drugs Market
10.3.6.4.1 Japan Atypical Antipsychotic Drugs Market by Drug Class
10.3.6.4.2 Japan Atypical Antipsychotic Drugs Market by Application
10.3.6.4.3 Japan Atypical Antipsychotic Drugs Market by Distribution Channel
10.3.6.5 South Korea Atypical Antipsychotic Drugs Market
10.3.6.5.1 South Korea Atypical Antipsychotic Drugs Market by Drug Class
10.3.6.5.2 South Korea Atypical Antipsychotic Drugs Market by Application
10.3.6.5.3 South Korea Atypical Antipsychotic Drugs Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Atypical Antipsychotic Drugs Market Overview
10.4.2 Middle East and Africa Atypical Antipsychotic Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Atypical Antipsychotic Drugs Market
10.4.6.1.1 South Africa Atypical Antipsychotic Drugs Market by Drug Class
10.4.6.1.2 South Africa Atypical Antipsychotic Drugs Market by Application
10.4.6.1.3 South Africa Atypical Antipsychotic Drugs Market by Distribution Channel
10.4.6.2 Saudi Arabia Atypical Antipsychotic Drugs Market
10.4.6.2.1 Saudi Arabia Atypical Antipsychotic Drugs Market by Drug Class
10.4.6.2.2 Saudi Arabia Atypical Antipsychotic Drugs Market by Application
10.4.6.2.3 Saudi Arabia Atypical Antipsychotic Drugs Market by Distribution Channel
10.4.6.3 U.A.E Atypical Antipsychotic Drugs Market
10.4.6.3.1 U.A.E Atypical Antipsychotic Drugs Market by Drug Class
10.4.6.3.2 U.A.E Atypical Antipsychotic Drugs Market by Application
10.4.6.3.3 U.A.E Atypical Antipsychotic Drugs Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Atypical Antipsychotic Drugs Market Overview
10.5.2 South and Central America Atypical Antipsychotic Drugs Market Forecasts and Analysis
10.5.3 South and Central America Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Application
10.5.5 South and Central America Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Atypical Antipsychotic Drugs Market
10.5.6.1.1 Brazil Atypical Antipsychotic Drugs Market by Drug Class
10.5.6.1.2 Brazil Atypical Antipsychotic Drugs Market by Application
10.5.6.1.3 Brazil Atypical Antipsychotic Drugs Market by Distribution Channel
10.5.6.2 Argentina Atypical Antipsychotic Drugs Market
10.5.6.2.1 Argentina Atypical Antipsychotic Drugs Market by Drug Class
10.5.6.2.2 Argentina Atypical Antipsychotic Drugs Market by Application
10.5.6.2.3 Argentina Atypical Antipsychotic Drugs Market by Distribution Channel

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. ATYPICAL ANTIPSYCHOTIC DRUGS MARKET, KEY COMPANY PROFILES
12.1. JANSSEN RESEARCH AND DEVELOPMENT, LLC (JOHNSON AND JOHNSON SERVICES INC)
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ELI LILLY AND COMPANY
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BRISTOL-MYERS SQUIBB COMPANY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ALLERGAN PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTRAZENECA PLC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANIS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. RANBAXY PHARMACEUTICALS INC. (SUN PHARMACEUTICAL INDUSTRIES LTD.)
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS

The List of Companies

1. Janssen Research and Development, LLC (Johnson and Johnson Services Inc)
2. Eli Lilly and Company
3. Pfizer Inc.
4. Bristol-Myers Squibb Company
5. Allergan plc
6. AstraZeneca plc
7. GlaxoSmithKline Plc.
8. SANIS
9. Ranbaxy Pharmaceuticals Inc. (Sun Pharmaceutical Industries Ltd.)
10. Teva Pharmaceutical Industries Ltd.

TIPRE00005402
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount